PROGNOSIS OF MUCINOUS HISTOLOGY FOR PATIENTS WITH RADICALLY RESECTED STAGE II AND III COLON CANCER

被引：0
|
作者：
Catalano, V [1 ]
Loupakis, F. [2 ]
Graziano, F. [1 ]
Bisonni, R. [3 ]
Torresi, U. [4 ]
Vincenzi, B. [5 ]
Mari, D. [6 ]
Giordani, P. [1 ]
Baldi, G. [2 ]
Santini, D.
Giustini, L. [3 ]
Silva, R. R. [6 ]
Falcone, A. [2 ]
D'Emidio, S. [1 ]
Rocchi, M. [7 ]
Fedeli, Luzi S. [1 ]
机构：
[1] AO Osped San Salvatore, Pesaro, Italy
[2] Univ Pisana, Oncol Univ 2, Azienda Osped, Pisa, Italy
[3] Osped Fermo, Rome, Italy
[4] Osped Macerata, Rome, Italy
[5] Univ Campus BioMed, Rome, Italy
[6] Osped Fabriano, Fabriano, Italy
[7] Univ Urbino, Ist Biomatemat, I-61029 Urbino, Italy
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Does Delay of Adjuvant Chemotherapy Impact Survival in Patients With Resected Stage II and III Colon Adenocarcinoma?
    Bayraktar, Ulas Darda
    Chen, Emerson
    Bayraktar, Soley
    Sands, Laurence R.
    Marchetti, Floriano
    Montero, Alberto Jose
    Rocha-Lima, Caio Max S.
    CANCER, 2011, 117 (11) : 2364 - 2370
  • [42] Targeted treatment for resected stage II and III rectal cancer
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (06) : 567 - 567
  • [43] Intensive screening for resected stage II and III colorectal cancer
    Fakih, Marwan
    COLORECTAL CANCER, 2012, 1 (01) : 71 - 81
  • [44] The number of lymph nodes examined as a poor prognosis factor in stage II and stage III colon cancer patients undergoing curative surgery
    Jeon, Jeongseok
    Shen, Lingjie
    Kim, Yitak
    Kim, Hyunwook
    van Gestel, Anna J.
    Han, Yoon Dae
    Han, Dai Hoon
    You, Seng Chan
    Ahn, Joong
    Shin, Sangjoon
    Geleijnse, Gijs
    Kim, Han Sang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] Chromosome 18q allelic loss and prognosis in stage II and III colon cancer
    Lanza, G
    Matteuzzi, M
    Gafá, R
    Orvieto, E
    Maestri, I
    Santini, A
    del Senno, L
    INTERNATIONAL JOURNAL OF CANCER, 1998, 79 (04) : 390 - 395
  • [46] The patient- derived cancer spheroid model predicts response to chemotherapy in curatively resected patients with high-risk stage II and stage III colon cancer
    Mayer, Barbara
    Held, Isabella
    Halfter, Kathrin
    Werner, Jens
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 53 - 53
  • [47] Metformin and risk recurrence in resected stage II/III colon cancer (CC) patients (pts): subgroup analysis from the TOSCA trial
    Di Bartolomeo, M.
    Rosato, G.
    Banzi, M.
    Pella, N.
    Zampino, M. G.
    Rimassa, L.
    Maiello, E.
    Marchetti, P.
    Lonardi, S.
    Labianca, R.
    Zaniboni, A.
    Sobrero, A.
    Ferrari, D.
    Bidoli, P.
    Iaffaioli, V.
    De Placido, S.
    Frassineti, L.
    Frustaci, S.
    Nicolini, M.
    Vernieri, C.
    Galli, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [48] Severe falls among older adults with resected stage II/III colon cancer receiving chemotherapy.
    LoConte, Noelle K.
    Allen, Glenn
    Leal, Ticiana A. B.
    Weiss, Jennifer
    Neuman, Heather B.
    Greenblatt, David Y.
    Schmacher, Jessica
    Gayle, Arlene Angela
    O'Connor, Erin S.
    Smith, Maureen
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [49] Adjuvant chemotherapy for resected stage II and III colon cancer: Comparison of widely used two prognostic calculators
    Bardia, A.
    Loprinzi, C.
    Grothey, A.
    Nelson, G.
    Alberts, S.
    Patiyil, S.
    Thome, S.
    Gill, S.
    Sargent, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] Adjuvant Chemotherapy for Resected Stage II and III Colon Cancer: Comparison of Two Widely Used Prognostic Calculators
    Bardia, Aditya
    Loprinzi, Charles
    Grothey, Axel
    Nelson, Garth
    Alberts, Steven
    Menon, Smitha
    Thome, Stephan
    Gill, Sharlene
    Sargent, Dan
    SEMINARS IN ONCOLOGY, 2010, 37 (01) : 39 - 46
12345